Search

Research on the Impact of Research and Development Subsidies on Technological Innovation of Pharmaceutical Companies

Author(s)

Sukun Liu1,2, Bin Yu1, Congjun Chu1,*

Affiliation(s)

1School of Economics and Management, Dalian Ocean University, Dalian, Liaoning, China 2Dalian Bank Postdoctoral Workstation, Dalian, Liaoning, China *Corresponding Author.

Abstract

Pharmaceutical enterprises' technological innovation exhibits significant externalities, and relying solely on market regulation can lead to market failure, necessitating intervention and guidance from regulatory authorities. This paper based on data from pharmaceutical companies listed on the stock market from 2009 to 2019, employs a panel fixed effects model to analyze the impact of R&D subsidies on technological innovation in pharmaceutical enterprises. The results indicate that R&D subsidies can promote the input of technological innovation in pharmaceutical enterprises, with a greater incentive effect on private enterprises than on state-owned enterprises. Therefore, regulatRoy authorities can appropriately increase subsidies for pharmaceutical enterprises and ensure that the subsidized funds are genuinely used for corporate technological research and development. At the same time, it is important to assist pharmaceutical enterprises in expanding channels for R&D funding and attract more social capital to be invested in corporate research and development. This study provides a reference basis for incentivizing technological innovation in pharmaceutical enterprises.

Keywords

Research and Development Subsidies; Pharmaceutical Companies; Technological Innovation; Heterogeneity Analysis

References

[1] Li W.F., Du J., Zhang H. Does Innovation Subsidies Stimulate Companies' Innovation Investment? New Evidence from Chinese Listed Companies. Financial Research, 2017, (10): 130-145. [2] Shu C, Wang Q, GAO S, et al. Firm Patenting, Innovations, and Government Institutional Support as a Double-edged Sword. Journal of Product Innovation Management, 2015, 32 (2): 290-305. [3] Catozzella, A., Vivarelli, M. The Possible Adverse Impact of Innovation Subsidies: Some Evidence from Italy. International Entrepreneurship and Management Journal, 2016, 12 (2): 351-368. [4] Yao D.M., Zhu Y.Y. Guidelines for Promotion or "Adding Frosting to the Cake"? Reexamination of the Causal Relationship between Fiscal Subsidies and Corporate Innovation Investment in China. Management Review, 2019, (6): 77-90. [5] Clausen T. H. Do Subsidies Have Positive Impacts on R&D and Innovation Activities at the Firm Level. Structural Change and Economic Dynamics, 2009 (4):239-253. [6] Shao, W., Yang, K., and Bai, X. Impact of Financial Subsidies on the R&D Intensity of New Energy Vehicles: A Case Study of 88 Listed Enterprises in China. Energy Strategy Reviews, 2021, 33(4):100580. [7] Lach Saul. Do R&D Subsidies Stimulate or Displace Private R&D? Evidence from Israel. Journal of Industrial Economics, 2002(4):369-390. [8] Zou Y., Ye Jinzhen, Li Bowen. The Impact of Government R&D Subsidies on Enterprise Innovation Output: An Empirical Analysis Based on the Mediation Effect Model. Journal of Shanxi University of Finance and Economics, 2019 (1): 17-26. [9] Zhou J.Y. The Impact of Government Subsidies on Performance of Pharmaceutical Manufacturing Listed Companies: A Mediating Effect Based on R&D Investment. Jiangsu Commerce Review, 2020, (02): 107-111. [10] Wen J, Feng G F. Heterogeneous Institutional Investor, Nature of Firm and Independent Innovation. Economic Research Journal, 2012, 47(03): 53-64.